Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Q&A
  • Published:

Challenge driven

Nature Nanotechnology volume 11, pages 401–402 (2016)Cite this article

Subjects

Nature Nanotechnology talked to Michael A. Meador, director of the National Nanotechnology Coordination Office in the US, about the way in which the US National Nanotechnology Initiative operates and how this has changed since its launch in 2001.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Challenge driven. Nature Nanotech 11, 401–402 (2016). https://doi.org/10.1038/nnano.2016.73

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nnano.2016.73

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research